SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-06-043591
Filing Date
2006-10-25
Accepted
2006-10-25 16:19:59
Documents
2
Period of Report
2006-10-25

Document Format Files

Seq Description Document Type Size
1 v055581_6k.htm 6-K 20929
2 GRAPHIC xtlbio.jpg GRAPHIC 5348
  Complete submission text file 0001144204-06-043591.txt   29750
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 061163104
SIC: 2834 Pharmaceutical Preparations